Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 300 results found. Search for [ serum institute clinical trials ]

Results 1 to 21 of 300
PTI
April 18, 2021
India is battling a massive surge in COVID-19 cases and health ministry data updated on Sunday showed that a record single-day rise of 2,61,500 coronavirus infections has taken the country's total tally to 1,47,88,109


BusinessToday.In
April 13, 2021
Russian Direct Investment Fund (RDIF) CEO Kirill Dmitriev added that Sputnik V's production at a larger scale will start by July 2021 with plans to produce 500 million doses


PB Jayakumar, Rai Vinaykumar
April 13, 2021
Indian vaccine manufacturers, including SII, Bharat Biotech, Panacea Biotech, Sanofi's Shanta Biotech, Biological E, Hester Biosciences and Zydus Cadila, have an installed capacity to manufacture 8.2 billion doses of different vaccines per year


PTI
March 27, 2021
India was one of the initiators of the 'Political Declaration on Equitable Global Access to COVID-19 Vaccines' that garnered the support of more than 180 UN member states


BusinessToday.In
March 19, 2021
Stelis and the RDIF plan to start supplying the vaccine doses in the third quarter of this year, said Strides Pharma. It is yet to be ascertained which countries the doses would go to


Rai Vinaykumar & Mudit Kapoor
March 13, 2021
India administered 1,87,55,540 first doses of the vaccine in the first 17 days of March. At this rate, it will take 2.36 years for India to vaccinate 70 per cent of its population with the initial dose of the two-dose regime vaccination programme.


BusinessToday.In
March 12, 2021
Denmark suspended the AstraZeneca Covid-19 vaccine on Thursday after many recipients reported blood clotting and one among them has allegedly \"died\". Norway and Iceland also followed the suit, scrapping the vaccine administration


Reuters
March 10, 2021
The US company pulled an application last month seeking emergency approval for its product in India after the drug regulator declined its request to skip a small local safety trial. That has kept its vaccine, developed with Germany's BioNTech SE, out of one of the world's biggest drug markets


BusinessToday.In
March 10, 2021
Deal was signed last week. Apart from India, SII is providing Covishield to several poor nations through COVAX facility being led by Gavi, Vaccine Alliance, World Health Organisation, Coalition for Epidemic Preparedness Innovations, and others


Rashi Bisaria
New Delhi, March 4, 2021
Digital media norms to be administered by Centre, not states The Information and Broadcasting (I&B) Ministry on Wednesday issued memorandum to states and union territories saying that the new rules for digital news publishers and over-the-top (OTT) platforms are to be administered by the Centre, not the states. The government had notified the Information Technology (Intermediary Guidelines and Digital Media Ethics Codes) Rules, 2021 on February 25. Defence equipment sales to India sho...


BusinessToday.In
March 4, 2021
Krishna Ella, Chairman of Bharat Biotech had earlier said the company is focusing on the intranasal vaccine as the existing vaccines require two-dose intramuscular injections and a country like India needs 2.6 billion syringes and needles which may add up to pollution


BusinessToday.In
March 3, 2021
Catch top stories from the world of business and economy with BusinessToday.In's Biz EOD report


BusinessToday.In
March 3, 2021
Data from 25,800 participants who received a vaccine or placebo in 1:1 ratio showed that the vaccine was well-tolerated; Bharat Biotech said the trial conducted with ICMR was the largest in India


BusinessToday.In
March 2, 2021
As senior citizens across the country take part in the vaccination drive, here is all the information they need two know about the two vaccines - Covaxin and Covishield


BusinessToday.In
February 19, 2021
As part of the review process, Dr Reddy's will present the safety profile of the phase 2 study, and interim data of the phase 3 study, which is expected to complete by 21st February 2021.


Joe C Mathew
February 19, 2021
Coronavirus vaccine: The Covid-19 vaccine candidate of Novavax is being studied in two ongoing pivotal Phase 3 clinical trials: in the United States and Mexico, as well as in the United Kingdom


PB Jayakumar
January 27, 2021
COVID-19 vaccine: About 19 vaccines are going to be globally available in the coming few weeks and months. Of this, about nine have already got emergency use authorisation


BusinessToday.In
January 25, 2021
As per the government's norms, it is mandatory for a foreign vaccine-making firm to conduct at least a Phase-3 trial with Indian volunteers even if it is approved outside India


PTI
January 22, 2021
There were no serious side effects in the participants enrolled for the phase 1 trial of Covaxin, according to the results published in The Lancet


BusinessToday.In
January 12, 2021
Among these vaccines are those developed by Zydus Cadila, Biological E and Gennova, along with Russia's Sputnik-V vaccine


PAGES 1 OF 15  12345